[This Week's Books] 'Conquering Alzheimer's' and More

Conquering Alzheimer’s

The U.S. Food and Drug Administration (FDA) officially approved the new dementia drug "Leqembi" (active ingredient: lecanemab), which slows the progression of Alzheimer’s, in July last year. Since then, Leqembi has been approved by South Korea’s Ministry of Food and Drug Safety as the fourth country in the world, following Japan and China. At this turning point in Alzheimer’s treatment, we examine the efforts made so far to treat Alzheimer’s and the future direction of Alzheimer’s treatment. (Written by Susumu Shimoyama / Translated by Han Sehee / Books Hill)

John Lee’s School of Wealth

This financial education book is composed of conversations between John Lee, who served as CEO of Meritz Asset Management from 2014 to 2022, and members of the "School of Wealth." The School of Wealth is a financial study group run by former CEO Lee. Lee points out that wealth is created through attitude, and for this reason, Korea is not yet a wealthy nation. He also emphasizes the importance of financial education, stating that having the right investment perspective and a long-term investment mindset is key. (Written by John Lee and participants of the "School of Wealth" / Medici Media)

Arthur Conan Doyle, A Collection of Onboard Mystery Short Stories

This is the first official Korean translation of "Tales of Pirates and the Blue Water," published in 1922 by John Murray, by British mystery writer Arthur Conan Doyle, author of the "Sherlock Holmes" series. It contains 10 exciting stories set at sea. The first six stories deal with mysteries occurring onboard, while the latter four stories cover the adventures of the notorious pirate Captain Shaki. (Written by Arthur Conan Doyle / Edited by Namgung Jin / Ritec Contents)

This content was produced with the assistance of AI translation services.